Showing results (311-320 of 2,330) with videos related to
Sort By:
Pageof 233
Clinical Drug Investigation|June 9, 2009
Effectiveness and tolerability of fixed-dose combination enalapril plus nitrendipine in hypertensive patients: results of the 3-month observational, post-marketing, multicentre, prospective CENIT studyAlejandro de la Sierra, Alejandro Roca-Cusachs, Josep Redón, et al.Clinical Drug Investigation|June 9, 2009
Onset of male gynaecomastia in a patient treated with sunitinib for metastatic renal cell carcinomaPierluigi Ballardini, Guido Margutti, Camillo Aliberti, et al.Clinical Drug Investigation|April 14, 2010
Effect of steady-state ambrisentan on the pharmacokinetics of a single dose of the oral contraceptive norethindrone (norethisterone) 1 mg/ethinylestradiol 35 microg in healthy subjects: an open-label, single-sequence, single-centre studyRebecca Spence, Arun Mandagere, Gennyne Walker, et al.Clinical Drug Investigation|April 14, 2010
Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre studySue Kelly, Emyr Davies, Simon Fearns, et al.Clinical Drug Investigation|April 14, 2010
Two cases of statin-induced rhabdomyolysis associated with mononeuropathyGian Paolo Fadini, Enzo Manzato, Cristina Crepaldi, et al.Clinical Drug Investigation|June 2, 2010
A cost-consequence analysis of pregabalin versus usual care in the symptomatic treatment of refractory low back pain: sub-analysis of observational trial data from orthopaedic surgery and rehabilitation clinicsCarles Morera-Domínguez, Félix Ceberio-Balda, Mariano Flórez-García, et al.Clinical Drug Investigation|May 17, 2007
Cost of Heart Failure in Patients Receiving beta-Blockers and Angiotensin-Converting Enzyme InhibitorsWilliam S Weintraub, Hugh Kawabata, Michele Tran, et al.Clinical Drug Investigation|December 14, 2006
Comparison of hyperbaric ropivacaine and hyperbaric bupivacaine in unilateral spinal anaesthesiaZekiye Bigat, Neval Boztug, Bilge Karsli, et al.Clinical Drug Investigation|December 14, 2006
Efficacy and safety of 24 weeks of therapy with bendroflumethiazide 1.25 mg/day or 2.5 mg/day and potassium chloride compared with enalapril 10 mg/day and amlodipine 5 mg/day in patients with mild to moderate primary hypertension : a multicentre, randomised, open studyS Rasmussen, N Borrild, J Vang AndersenClinical Drug Investigation|December 14, 2006
Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observationMarc Ziegenbein, Georg Wittmann, Stefan KroppPageof 233